DNA day on April 25th, celebrates major scientific achievements concerning DNA, in particular the completion of the Human Genome Project in 2003 and the discovery of DNA’s double helix…

Rapid and reversible aptamer binding is helping to build new in vivo biosensors that will change the way we diagnose and treat disease. Dr Netz Arroyo is an Assistant Professor…

In the recently published paper in Talenta from Dr Mark Platt and the team at Loughborough University, they demonstrate a novel approach for aptamer biosensors to detect…

Detecting and quantifying small molecule analytes can be difficult. Our specially designed displacement approach allows us to select aptamers that can directly be used in various biosensor platforms for…

There is an increasing interest in developing new biosensors for diagnostics and basic research applications. In light of the emerging aptamer technology, aptamer-based biosensors (Aptasensors) are expected to be…

Cystic fibrosis (CF) is one of the most lethal autosomal recessive disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). It is estimated that…

Benefits of Aptamers for Protein Applications Proteins play significant roles in the physiological and pathological mechanisms of living organisms including human beings. There is an increased demand for convenient methodologies…

Although the world is focused on the COVID-19 virus, it is the envelope proteins that are helping companies to develop all important tests. Benefits of Aptamers…

29th November 2018 This month: Aptamer Group data on selective bind and elution reusability of aptamer  purification columns Small molecule analysis webinar with Pall ForteBio BLI platform Our CEO…

1st August 2018 Scientists from the Technical University of Denmark, led by Krishna Kant have published a new review in Biotechnology Advances including  aptamer-based approaches  for…